Generics 139

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Deflazacort manufacturers

139 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

139 products found

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850
This pharmaceutical company boasts over two decades of experience in manufacturing generic drugs and offering third-party manufacturing services. They have a dedicated team of experienced professionals overseeing operations, marketing, and sales across the EU and North America. Their own manufacturing unit ensures quality control, adhering to WHO GMP compliance. The company focuses on several key therapy areas, including neurology and pain management, with a range of principal dosage forms such as gels. They hold product patents and are trusted by leading physicians in both urban and rural areas.

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #21247

This CTD dossier owner and manufacturer is a leading pharmaceutical manufacturer in India, with production facilities in South Asia. They are known for producing high-quality generic medications across a range of therapy areas including antibiotics, analgesics, cough remedies, gastrointestinal treatments, and immune boosters. They offer various dosage forms such as tablets, capsules, liquids, powders, ointments, creams, ear drops, and enemas. The company holds several GMP certifications and has received numerous awards for quality, productivity, and ethical business practices from both national and international bodies. They are committed to making medicines affordable and accessible throughout the country.

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20428

This CTD dossier owner and manufacturer is a progressive pharmaceutical manufacturer in India, specializing in the development, manufacturing, and marketing of pharmaceutical, OTC, and nutraceutical products. With a focus on innovation, simplicity, and cost-efficiency, the company aims to deliver high-quality healthcare solutions across India and is planning to expand globally. Committed to providing excellent quality products, the company adheres to strict standards certified by organizations like WHO, US-FDA, GMP, and ISO 9001. With a strong emphasis on quality, Viribus Healthcare ensures that its products are reliable and safe for end users, establishing itself as a trusted name in the pharmaceutical industry.

Want to see all 139 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Deflazacort is used as an immunosuppressant and also as an anti-inflammatory medication. It is popular in the United Kingdom with its trade name used by the manufacturers and distributors, Calcort. This drug was patented in the year 1965. Medical use of this drug began in 1985. Also referred to as Emflaza by the manufacturers, this corticosteroid is useful for managing the symptoms of Duchenne Muscular Dystrophy [DMD]. The leading Deflazacort manufacturer is Marathon Pharmaceuticals. This drug was approved by the FDA in the year 2017.
Duchenne Muscular Dystrophy results because of the mutations in the dystrophin gene. This gene is crucial for muscle function. The condition can result in cardiovascular disability, progressive breathing, and serious muscle weakness. The disease manifests by resulting in extreme muscle fatigue followed by the loss of ability to walk by the age of 7.
Deflazacort assists in delaying the onset of complications in muscles. This further prolongs the lives of children who have been diagnosed with the condition. The medication can lower the harmful effects on bone health in comparison to other steroid medications being offered by the trusted pharma manufacturers.
Deflazacort cannot be considered to be a cure for muscular dystrophy. However, it does strengthen the muscles and also slows down the progression of disability. The NHS prescription price for 6mg of this drug is £9.00. The wholesale cost may be a little lesser than this. Apart from being beneficial to muscles, this drug can also help with conditions such as Asthma, Crohn’s Disease, Lymphatic Leukemia, multiple myeloma, Pemphigus, Sarcoidosis, Ulcerative colitis, juvenile chronic arthritis and many more.
The FDA approved a fast track status in January 2015 to Marathon Pharmaceuticals for treatment of Duchenne Muscular Dystrophy which is a rare and fatal disease. The CEO of this pharmaceutical manufacturing company made an announcement about the launch of this drug amidst controversy surrounding the steep price of the drug. The price at which the drug was being launched was 70 times more than it would cost in other nations overseas.
The conditions have now changed as far as the wholesale price of this drug is concerned. As the drug has been approved in several nations, the Deflazacort manufacturers are now offering it at lower rates. For instance, in Canada, the drug can be purchased for $1 per tablet. The Deflazacort suppliers are offering this drug under the trade name after the rights were purchased by PTC Therapeutics Inc. from Marathon Pharmaceuticals. In the United Kingdom, Deflazacort suppliers use the trade name Calcort. In Brazil, the distributors use the trade name Cortax or Defcort.
Most companies argue the price for this drug is exorbitant. Initially, the price was indeed more. However, the CEO of the company during the launch of the drug in the US stated that the price tag was due to the evaluation of future dynamics of the market. The net price of Deflazacort has now reduced. Though controlling the price in the future is going to be a challenge for the companies holding the license to manufacture this drug.
If you are a distributor, then you can make good use of the opportunity available and secure a great deal for Deflazacort from the leading manufacturers on Pipelinepharma. You can achieve the best cost/benefit ratio by bypassing lengthy sourcing, negotiation, and ordering process.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

We use cookies to offer you a better user experience, provide special features or analyze anonymous traffic data. Find out more about how we use cookies .